ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,436.21
0.67%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mersana Therapeutics Inc (MRSN)

  7. Mersana Therapeutics Inc (MRSN) News

Mersana Therapeutics (MRSN)

Mersana Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRSN
DateTimeSourceHeadlineSymbolCompany
15/11/202421:45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
14/11/202422:45Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
13/11/202416:00AllPennyStocks.comThis Particular Biotech Stock Is Soaring On Two Key AnnouncementsNASDAQ:MRSNMersana Therapeutics Inc
13/11/202413:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
13/11/202412:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
13/11/202412:00GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
06/11/202413:00GlobeNewswire Inc.Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024NASDAQ:MRSNMersana Therapeutics Inc
29/10/202420:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
29/10/202420:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
15/10/202410:55Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
07/10/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
04/10/202400:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
13/09/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
13/09/202421:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRSNMersana Therapeutics Inc
13/08/202412:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRSNMersana Therapeutics Inc
13/08/202411:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
13/08/202411:00GlobeNewswire Inc.Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial ResultsNASDAQ:MRSNMersana Therapeutics Inc
06/08/202412:00GlobeNewswire Inc.Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024NASDAQ:MRSNMersana Therapeutics Inc
12/06/202421:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
12/06/202420:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
12/06/202420:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRSNMersana Therapeutics Inc
11/06/202420:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRSNMersana Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MRSN

Your Recent History

HUOB
ALGOETH
Algorand
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Silver

    1 year 40%, 2 years 50% and *3 years 60%

    *Across 3 years £903.96 only 361.58